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Introduction: Incidence and prevalence for human immunodeficiency virus (HIV) has yet to 
experience a significant decline. Increasing provider knowledge regarding use of Pre-Exposure 
Prophylaxis, an HIV prevention drug, correlates with increased provider risk screening & 
prescribing PrEP. Standardized patient (SP) simulation is an effective teaching method for 
healthcare students to increase knowledge and confidence in providing sexual healthcare.  
Purpose: The purpose of this project was to evaluate an educational program aimed at increasing 
participant knowledge attainment and self-confidence in the ability to ascertain a sexual health 
history and advance the participant’s ability to manage PrEP candidates in a primary care setting.  
Intervention: Sixteen participants attended a didactic lecture based on CDC guidelines on the 
role of primary care in comprehensive sexual healthcare screening and HIV prevention and 
intervention using PrEP prescription. Lecture was followed by a standardized patient (SP) 
simulation in which participants applied didactic content to perform a patient risk assessment, 
comprehensive sexual health screening, and PrEP management and follow-up.  
Results: Post-intervention total knowledge percent improved by 53%. Confidence in identifying 
PrEP candidates, eliciting a sexual health history, and synthesizing plans all improved post 
simulation. Participant responses reflected overall satisfaction and self-confidence in learning 
after conclusion of simulation. 
Discussion: Implementation of a sexual healthcare screening and PrEP SP simulation is a 
successful adjunct to traditional didactic teaching to reinforce student knowledge and confidence.  
 
Key words: human immunodeficiency virus; pre-exposure prophylaxis; standardized patient 
simulation; adult learner; prevention; primary care; sexual healthcare; knowledge; risk screening 
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The Use of Simulation to Practice Pre-Exposure Prophylaxis Sexual Health Risk Screening, 
Management, and Follow-up within a Doctor of Nursing Practice Program 
           After several years of decreased incidence of HIV, the rate of new HIV infections has 
plateaued, partly due to ineffectively reaching high-risk individuals with preventative measures 
(Centers for Disease Control and Prevention, 2019).  The HIV preventative medication, PrEP, 
has low implementation nationwide as synthesized by the narrative review performed by 
Silapaswan et al. (2016). A minority of at-risk individuals who could benefit from PrEP are 
taking the medication due to a limited number of health care providers trained and confident in 
sexual health screening, along with prescribing and managing PrEP (Blumenthal et al., 2015). 
Addressing this barrier requires educating future primary care providers in this preventative 
health intervention.  
                                        Background of the Problem 
In 2017, 38,739 individuals were newly infected with the human immunodeficiency virus 
(HIV), with approximately 1.1 million individuals 13 years or older living with HIV in the 
United States. Approximately 15% of these individuals are unaware of their HIV status, 
increasing the likelihood of transmission (CDC, 2019). Men who have sex with men (MSM), 
black homosexual and bisexual young adult males ages 13 to 29 years, injection drug users, 
Latinos, African Americans, and transgender women are especially vulnerable to the HIV 
epidemic. Priority locations such as the southern United States and metropolitan areas are at the 
forefront for HIV exposure. HIV rates declined from 2010 to 2013, but plateaued in 2016. The 
Centers for Disease Control and Prevention (CDC) estimates that the HIV rate has stabilized as a 
result of ineffectively reaching these disproportionate populations with HIV preventative 
measures (2019).  
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The combination antiretroviral drug tenofovir disoproxil fumarate emtricitabine 
(TDF/FTC), or PrEP, is the first Food and Drug Administration (FDA) approved medication for 
the prevention of HIV with almost a 92% efficacy for those with detectable drug levels (CDC, 
2017). PrEP was federally approved for adults ages 18 and older in the United States in 2012. In 
September 2017, the ATN-113 was the first trial to include adolescents MSM ages 15 to 17 
(Gray, Shenoi, & Dillingham, 2018). Trial results indicated PrEP was safe and efficacious for 
youth. Influenced by this study, PrEP was approved by the Food and Drug Administration on 
May 25, 2018 for youth over 35 kilograms (U.S. Department of Health & Human Services, 
2018b). Prevention through the prescription and usage of PrEP is an approach that promotes the 
National/AIDS Strategy for the United States desired outcome of reducing the number of new 
HIV diagnoses by 25% by 2020 (U.S. Department of Health & Human Services, 2018a). 
Approximately 1.1 million Americans are at risk for HIV transmission as a result of their risk 
factors, but only 90,000 have been prescribed PrEP (Federal HIV/AIDS Web Council, 2018). 
Under-prescribing PrEP increases the likelihood of HIV exposure among serodiscordant 
couples and those at high-risk for HIV exposure. HIV providers with the knowledge and skill to 
prescribe PrEP are limited in number and rarely provide care for HIV-negative patients. In 
contrast, primary care providers are greater in number and are more likely to encounter patients 
who are high-risk, but HIV negative. Recently, Petroll and colleagues (2017) surveyed 525 HIV 
care providers and primary care physicians. Approximately 98% of HIV providers had received 
knowledge of PrEP compared to only 76% of primary care physicians. Primary care providers 
voiced concerns on their limited PrEP knowledge and skills in identifying patients high-risk for 
HIV exposure, risk-reduction counseling, and follow-up monitoring. The use of simulation in a 
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healthcare classroom would allow students and medical providers to advance their PrEP and 
sexual healthcare knowledge and skills that are not consistently developed in clinical practice. 
                                             Review of the Literature  
 Identification of simulation as an evidence-based teaching method occurred through a 
literature search of CINAHL, PubMed, and Ovid databases with the key words “standardized 
patient simulation” and “primary care”. Results were limited by publication in the last ten years 
and resulted in 6,358 articles. An advanced search including key words “sexual healthcare”  and 
“PrEP” generated articles with various healthcare topics not explicit sexual healthcare or PrEP. 
The Institute of Medicine (IOM), recommends simulation as a method to teach students 
effective responses to multilayered clinical circumstances (Galloway, 2009). To be effective, the 
student experience should be integrated into the student curriculum, provide deliberate feedback, 
and be outcome driven (Motola, Devine, Chung, Sullivan, & Issenberg, 2013). Studies support 
simulation as an evidence-based method that correlates with effective skill retention, knowledge 
retention, and comfort providing healthcare to patients (Fitzpatrick et al., 2012; McLaughlin, 
Monahan, Doezema, & Crandall 2007). Using simulation as an educational learning experience 
allows students and healthcare providers to advance their sexual health skills and solidify their 
learning in a safe environment.   
Bambini and colleagues (2009) performed a quasi-experimental study sampling 112 
undergraduate nursing students. Confidence in postpartum and newborn nursing skills was 
assessed after a simulation experience. Self-efficacy scores increases from a mean of 28.66 to 
42.14 prospectively. Patient education and clinical skills also improved. The authors determined 
this method of learning led to skill retention and improved clinical patient interview abilities. 
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The authors also concluded that simulation cultivates three qualitative results for analysis: 
communication, self-assurance, and clinical judgment (Bambini, Washburn, & Perkins, 2009).  
Addressing sexual healthcare and HIV status warrants challenging conversations between 
healthcare providers and patients. Boss and colleagues (2012) observed 10 neonatology 
physicians in a simulation including a challenging conversation with a female having a preterm 
birth at 23 weeks. Post encounter surveys and debriefing helped reproduce the decisional context 
of this challenging conversation with 75% of physicians feeling sure of their decisional making 
capacity after simulation. Ford and colleagues (2010) compared the benefits of didactic lecture to 
simulation in the intensive care unit. Medication errors were reduced among the12 nurses who 
participated in the simulation by 26.8%, providing evidence that simulation increases participant 
competency and patient safety. Acknowledging previous study outcomes in other challenging 
areas of healthcare, patient simulation with a HIV high-risk patient could assist in improving 
sexual healthcare screening confidence and communication related to PrEP candidacy.  
Theoretical Framework  
Knowles’ Adult Learning Theory provided the conceptual framework for this program. 
The theory incorporates five assumptions of the adult learner: (a) self-concept, (b) adult learner 
experience, (c) readiness to learn, (d) orientation to learning, and (e) motivation to learn 
(Malcolm, 1978). Knowles established that adults are self-directed learners that benefit from 
exploring a topic autonomously. Relevant and useful information is necessary to encourage 
active involvement in adult learning. Length and intensity of the experience contains value, but 
also a person’s culture or belief system. Adult learners excel with brief guidelines void of useless 
details (Malcolm, 1978). Understanding Knowles’ assumptions of the adult learner, Knowles’ 
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Adult Learning Theory was used to guide the implementation of a PrEP educational program as 
illustrated in Figure 1. 
Figure 1 
Application of Knowles’ 4 Principles of Andragogy to a PrEP Educational Program (Malcolm, 
1978).  
 
Setting and Organizational Assessment 
The program was conducted at a public university located in a metropolitan area in the 
Midwestern United States. This program was provided to all family and adult/gerontology 
primary care nursing practice students in their third year of study in the Doctor of Nursing 
Practice (DNP) program. The didactic component of the program was recorded and provided to 
the program participants in an university classroom. The simulation activities took place in the 
school of nursing simulation lab. Permission was obtained from University of Louisville’s DNP 
program director Dr. Sara Robertson.   




The purpose of this project was evaluate an educational program aimed at increasing 
participant knowledge attainment and self-confidence in the ability to ascertain a sexual health 
history, provide sexual health care in the primary care setting, as well as to advance the 
participant’s ability to properly identify, manage, and counsel PrEP candidates. 
Intervention 
Participants listened to a 30 minute pre-recorded didactic lecture based on CDC 
guidelines identifying the role of primary care in the completion of a comprehensive sexual 
healthcare screening and implementation of an HIV prevention strategy using PrEP. Lecture was 
divided into two 15-minute sections. Participants had the opportunity to apply the information 
learned through a standardized patient simulation.  
The standardized patient (SP) simulation included a pre-briefing via a door chart detailing 
physical assessment parameters and summary of the clinical scenario. The door chart detailed the 
SP’s chief complaint, demographic information, and vital signs. The participants were each 
paired with a SP of whom the participants did not meet until entering the examination room. SPs 
were trained prior to the scenario and were given a script to follow during the simulated clinical 
experience (see Appendix A). All SPs were trained by the student investigator to help maintain 
internal validity.  
The SPs were also provided with cue cards to ensure consistency between simulations. 
The cue cards included positive or negative affirmation of subjective and objective data. If a 
participant asked a question that could be answered by a cue card, the SP presented the cue card 
to the participant. If the participant asked a question that was unrelated to the simulation, the SP 
was instructed to answer that such subjective or objective data is within defined limits. After the 
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simulation concluded, the participants were moved to a private room and were provided the 
opportunity to order laboratory tests and receive results to determine the next phase of care.  
The participants were asked to compose a Subjective, Objective, Assessment, and Plan 
(SOAP) note to solidify content learned from simulation. Participants used information from SP 
subjective histories, physical assessments, and laboratory test results to help determine a 
diagnosis and formulate a plan for management and follow-up. Participants were also given a 
condensed PrEP and sexual healthcare screening informational handout that they could use to 
help compose their SOAP note (see Appendix B). The SOAP note was self-assessed by the 
participant based on a rubric for inclusion of specific subjective and objective data, assessment, 
and plan (see Appendix C). The student investigator held a 10-minute group debriefing with all 
participants at the end of the scenario.  The learning outcomes were addressed during this session 
and any questions or concerns the participants had were answered. After the debriefing session 
concluded, each participant completed the posttest and the NLN student satisfaction and self-
confidence in learning tool.  
The simulation activity including pre-activity education, simulation experience, write up 
and debrief lasted a total of 6 hours. Prior to implementation, permission for the educational 
program was submitted to the University of Louisville Institutional Review Board. The quality 
improvement project was deemed non-human subjects research.  
Participants 
Participants included sixteen family and adult/gerontology primary care nurse 
practitioner students in their third year of graduate level nursing at the University of Louisville.  
Data Collection  
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The pretest with a preamble consent was distributed in paper copy at the beginning of the 
program (see Appendix D). Participants were randomly assigned a number one to sixteen by an 
independent faculty member. Participant IDs were used for the entirety of the program to 
maintain anonymity and to pair pre and posttest results. The participants were allotted 15 
minutes to complete each the pre and posttest. The posttest was distributed in paper copy at the 
completion of the program. Participants submitted their pre and posttests anonymously into a 
slotted collection container.  
Measurement 
The educational program pretest was comprised of participant demographics including age, 
race, and gender. Three 4-point Likert-type items (1=Extremely Lacking in Confidence and 
4=Very Confident) addressed whether the participants felt confident in meeting the educational 
program objectives (identifying PrEP candidates, eliciting a sexual health history, and synthesizing 
plans for high-risk sexual practice patients). Nine multiple-choice style knowledge questions 
regarding PrEP and sexual healthcare understanding were examined (see Appendix E). A single 
point was given for each correct answer, while no points were awarded for an incorrect answer. 
Knowledge scores were totaled for each participant ranging from one to nine. The posttest included 
the same three 4-point Likert-type questions and nine knowledge questions.  
Along with the posttest, the Student Satisfaction and Self-Confidence in Learning 
Survey, created by the National League of Nursing (NLN), was administered (see Appendix F). 
Permission to use the Student Satisfaction and Self-Confidence in Learning Survey after the 
educational program was given by Amy McGuire, program manager for the NLN. The survey is 
a 13-item tool intended to measure student satisfaction with simulation and self-confidence in 
simulation learning, both using a 5-point scale, with a higher score demonstrating increased 
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satisfaction and/or self-confidence. Participants completed five questions measuring student 
satisfaction and eight items measuring self-confidence in learning. Jeffries and Rizzolo (2006) 
reported a reliability of 0.94 for the satisfaction subscale and 0.87 for the self-confidence 
subscale. 
Results 
A total of 16 DNP students, ages 23-48 (M=30.75, SD=6.85), participated in the program 
and completed surveys. The majority of participants were aged 26 to 35 years old. Females 
represented the entirety, with 81.3% Caucasian. A majority of the participants, 56.2%, did not 
have any experience in their nurse practitioner clinical rotation discussing PrEP as a treatment 
option with high-risk sexual behavior patients. The remaining 43.75% had the opportunity to 
discuss PrEP with patients, but most did not actually prescribe the medication. Only 12.5% of 
participants had prescribed PrEP in conjunction with their preceptor in their clinical rotations. 
Positively, most participants, 87.5%, had experience providing healthcare for both LGBTQ and 
high-risk sexual behavior. Participant demographics and clinical experience are further outlined 
in Tables 1 and 2. SPSS Version 26 was used for all results data analysis and organization of 
tables.  
Table 1 
 Participant Demographics  
N = 16 Doctor of Nursing Practice Students  
Demographic Variable N (%) 
 
Gender  
        Female  
        Male  
 
16 (100.00) 
0   (0.00) 
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Age in years: 
         23          
         25 
         26 
         27 
         28 
         31 
         32 
         35 
         36 
         43 














         White/Caucasian 
         Black/African American 
         Prefer not answer 
 
13  (81.25) 
2  (12.50) 
1  (6.25) 
 
Table 2 
Sexual Healthcare Screening and PrEP Clinical Experience 
N = 16 Doctor of Nursing Practice Students  
Clinical Experience  N (%) 
 
Clinical experience in providing 
healthcare for LGBTQ?  
          Yes  




2   (12.50) 
Clinical experience in providing 
healthcare for high-risk sexual 
behavior? 
          Yes  





2   (12.50) 
Clinical experience discussing 
PrEP? 
          Yes 
          No  
 
 
7   (43.75) 
9   (56.25) 
Clinical experience prescribing 
PrEP? 
          Yes  
          No  
 
 
2   (12.50) 
14 (87.50) 
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A knowledge questionnaire containing nine multiple choice items regarding PrEP and 
sexual healthcare screening was administered both before and after the PrEP educational 
program. A paired samples t-test (Table 3) was conducted to evaluate the impact of didactic 
lecture and SP simulation intervention on participant PrEP and sexual healthcare knowledge 
scores. Total correct knowledge scores of all nine test questions were converted into a 
knowledge percent ranging from 0-100.  Knowledge percent increased significantly from pretest 
(59.56 ± 17.43) to posttest (91.06 ± 9.18), t(15) = 7.01, p <.0001). The mean increase in correct 
knowledge percent was 31.50 with a 95% CI ranging from 21.92 to 41.08. The magnitude of 
effect was large (eta squared = .78).  
Table 3  
Paired T-test Comparison of Total Correct Knowledge Percent Pre and Post Intervention  
 
 Mean ± SD 
 
t df  p  
Pretest Knowledge Percent 
(N = 16) 
59.56 ± 17.43 7.01 15 <.0001 
Posttest Knowledge Percent 
(N = 16) 
91.06 ± 9.18    
 
Descriptive Statistics (Table 4) were used to describe the impact of an SP simulation 
intervention on participant confidence in meeting three outcome objectives: identifying 
candidates for PrEP, eliciting a sexual health history, and synthesizing a plan for a high-risk 
sexual practice patient. Confidence scores were rated by participants from one to four 
(1=Extremely Lacking in Confidence and 4=Very Confident) on both participant pretest and 
posttest.  
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Confidence in identifying candidates for PrEP, increased from pretest (M=2.50, 
SD=0.63) to posttest (M=3.13, SD=0.62). Both pretest and posttest confidence scores ranged 
from two to four. The mean increase in confidence scores was 0.63.  
Confidence in eliciting a sexual history increased from pretest (M=3.13, SD=0.50) to 
posttest (M=3.56, SD=0.51). Pretest confidence scores ranged from two to four, compared to 
posttest scores which ranged from three to four. The mean increase in confidence scores was 
0.43.  
Confidence in synthesizing a plan for high-risk sexual practice patients increased from 
pretest (M=2.31, SD=0.48) to posttest (M=3.19, SD=0.40). Pretest confidence scores ranged 
from two to three, compared to posttest scores which ranged from three to four. The mean 
increase in confidence scores was 0.88.  
Table 4 
Comparison of Pre and Post Intervention Participant Confidence  
 Pretest Mean  
 
Posttest Mean  Change in Mean 
Confidence from Pre to 
Posttest  
 
Confidence Score in 
Identifying Candidates for 
PrEP 
(N=16) 
2.50  3.13 0.63 
Confidence Scores in Eliciting 
a Sexual History 
(N=16) 
3.13 3.56 0.43 
Confidence Scores in in 
Synthesizing a Plan for High-
Risk Sexual Practice Patients 
(N=16) 
2.31 3.19 0.88 
 
The 13-item NLN Student Satisfaction and Self-Confidence in Learning Survey (National 
League for Nursing, 2019) was administered following the simulation. Responses to the survey 
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were analyzed descriptively and are illustrated in Table 5. The survey comprised two separate 
sections that were subtotaled independently. The participants had a mean satisfaction score of 
21.50 ± 3.03 (maximum possible = 25) and a mean self-confidence score of 29.44 ± 3.44 
(maximum possible = 35).  
Table 5  












Mean Score of 














16 12 23 35 29.44 3.44 
 
A single open-ended response allowed participants to describe what they liked, did not 
like, or what could be improved regarding the patient simulation. Four of 16 participants 
responded. Four participants provided constructive feedback. Live lecture, rather than recording 
was preferred. Separating didactic content and simulation into different days was suggested to 
allow additional comprehension of material. One participant reported satisfaction that the 
simulation experience provided additional opportunity to formulate a plan for a patient that could 
be applied to future practice. Another participant reported an increase in self-confidence in 
collecting inclusive subjective data.  
 
 





Results suggest that implementation of a sexual healthcare screening and PrEP SP 
simulation in a graduate level nurse practitioner course was a successful adjunct to traditional 
didactic teaching to reinforce student knowledge, application of skills, and confidence in 
learning. Responses from participants reflected overall satisfaction and self-confidence in 
learning after conclusion of simulation experience. The educational program was generally well 
received by participants; however, feedback included the suggestion of a live rather than 
recorded lecture and to provide the opportunity for questions. Moving directly from lecture to 
simulation was also an area of concern because it prevented participants from processing lecture 
content. Providing didactic content earlier could allow for easier comprehension and application 
of content in simulation.  
 Participants’ confidence in identifying PrEP candidates, eliciting a sexual health history, 
and synthesizing plans all improved post-education and simulation. The two students with 
previous nurse practitioner clinical course experience in providing healthcare for high-risk sexual 
behavior had a higher mean confidence score (3.29 ± .47) than those without experience (2.50 ± 
.71) in eliciting a sexual health history. Graduate education encompassing pharmaceutical HIV 
prevention measures and sexual healthcare follow-up improved confidence in identifying PrEP 
candidates and formulating a plan for patients with high-risk sexual behaviors.  
Post-intervention total knowledge percent improved by 53%, indicating that application 
through simulation has the ability to increase student test scores. Findings were consistent with 
previous studies that examined the outcome of simulation and found improvement in students’ 
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knowledge and confidence providing this type of specialized healthcare (Fitzpatrick et al., 2012; 
McLaughlin, Monahan, Doezema, & Crandall 2007) 
Limitations 
Limitations of this project included implementation in a single university setting and 
small sample size which impacted generalizability of results.  Purposive sampling used in 
selecting DNP students in their third year also limited this project. This sampling method 
increased the risk of response bias from participants. Self-reported measures were used for both 
the NLN survey to determine satisfaction and self-confidence in simulation learning and pretest 
and posttest confidence in meeting outcome objectives. Self-reported measures may have been 
subject to interpretation bias by participants. Variations in participant previous PrEP and sexual 
healthcare screening experience prior to implementation may have effected pre and post 
knowledge assessment and satisfaction with simulation. Participants with greater initial 
knowledge scores would have limited opportunity to increase scores. Lastly, lack of long-term 
prevented the determination if simulation transfers to future clinical practice.  
Conclusion 
The simulation educational program addressed future family and adult/gerontology 
primary care doctor of nursing practice students’ knowledge of PrEP and sexual health care 
screening in an effort to increase this innovative preventative medication to viable HIV at-risk 
candidates in clinical practice. The simulation experience was an effective tool in improving 
provider satisfaction and self-confidence in learning PrEP management and sexual healthcare 
screening. 
If integrated into a DNP program, the simulation program could improve quality in 
clinical education by increasing pre-clinical learning regarding PrEP. With increased simulation 
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programs in sexual healthcare screening and PrEP management, future providers may have 
improved knowledge and confidence in delivering PrEP counseling and preventative medicine 
with the long-term outcome of decreasing HIV incidence.  
Suggested program improvements could include assessment of participant SOAP notes 
with rubric score to provide additional quantitative and qualitative data for analysis. The 
simulation program could also expand into an interdisciplinary setting that includes other 
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Appendix A  
Standardized Patient Script  
Simulated Patient Script – High-Risk Sexual Patient  
 
Scenario: John Brown is a 25-year old Caucasian male who presents to your primary care clinic. He presents today 
with a chief complaint of rhinitis after a recent move to Kentucky. He has not been to a primary care provider in 
seven years. 
 




Chief Complaint:  
I’ve had a runny nose for the past week that just won’t stop. I’ve never had this problem until I moved to Kentucky.   
 
History of Present Illness:  
 
Onset: My runny nose began about a week ago. 
 
Location: It irritates my nose and the back of my throat.  
 
Duration: It seems like it never stops running, except when I wake up the morning congested at first.  
 
Characteristics: The mucus is clear. My throat feels like it has mucus running down the back.  
 
Aggravating Factors: It’s worse when I go outside. 
 
Relieving Factors: I’ve used some nasal spray from the drug store that seems to help some.  
 
Timing: My nose and the mucus in the back of my throat has been somewhat constant throughout the day.  
 
Past Medical History:  
- I had the flu 3 months ago, but I feel much better now except for the irritation with my nose and throat. I’ve been 
relatively healthy.  
*Only if asked: I’ve never been told I have any type of Hepatitis or HIV.  
 
Past Surgical History:  
- I’ve never had surgery.  
 
Hospitalizations:  
- I haven’t had any hospitalizations.  
 
Current Medications:  
- I’m not on anything from a doctor. I’ve just used the saline nasal spray for the last few days.  
 
Allergies:  
- I don’t have any allergies.  
 
Social History:  
- Smoking: I don’t smoke tobacco or e-cigarettes.  
- Alcohol: I drink 5-6 drinks on the weekend days, maybe more, but I don’t drink during the week. 
- Drug Use: I smoke marijuana on rare occasions, but I’ve never used IV drugs.   
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- Career/Job: I’m a nursing assistant at the hospital.  
- I live by myself. I have no children.  
  
Immunizations:  
- I had all my childhood immunizations that I know of.   
*Only if asked: I haven’t had the HPV vaccination, but I’ve had the Hep A and B. 
 
Family History:  
- My mom has allergies and my sister has asthma.  
- I think my dad has high blood pressure.  
 
Reproductive/Sexual History:  
 
-Yes I am sexually active.  
 
Gender born, gender identity, sexual orientation: 
- I was born male and prefer the pronoun “he”. I would consider myself bisexual.  
 
5 P’s of Sexual Health:  
 
Partners: I had four male and two female sexual partners in the last couple of months. I’ve had two additional male 
partners in the last year.  
 
Practices: I had (receptive) anal sex with all male partners, vaginal sex with both female partners, and oral sex with 
all partners.  
*Only if asked: I’ve never been paid for any type of sex. 
 
Protection from STIs: I only wear condoms with female partners sometimes. I don’t like how they feel.   
 
Past History of STIs: I had Chlamydia when I was 19 but they gave me an antibiotic and I was retested. I don’t 
have it anymore. My last partner had Chlamydia.  
*Only if asked: I would like to have STI or HIV testing.  
   




Review of Systems (ROS): 
 
* If any ROS is not on the list below, please deny any symptoms.  
 
General: When asked any of the following: Have you had any fever, chills, fatigue, night sweats, loss of appetite, 
recent unintended weight loss? 
Answer: No I’ve felt well lately.  
 
Skin: When asked any of the following: Do you have any new rashes, growths, lesions, burning, or itching? 
Answer: I don’t have any new skin problems that I know of.  
 
HEENT: When asked any of the following: Have you had a headache, any changes in vision, itchy or watery eyes, 
pain or fullness in your ears, sore throat, nasal congestion, or oral lesions or discharge? 
Answer: I’ve had a runny nose and a bit of a sore throat with the drainage running down my throat. Everything else 
seems ok. I haven’t noticed any sores in my mouth.  
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Genitourinary: When asked any of the following: Have you had any urinary frequency or trouble urinating? Have 
you had any blood in your urine, foul odor, or any other change? Do you have any penile lesions, sores, or 
discharge? Any painful ejaculation? Any testicular masses or rash? 
Answer: I’ve had some occasional dark urine after drinking. It hasn’t burned when I pee and I’m not going any more 
than usual. I haven’t had any discharge or sores either.  
 
Rectal: When asked any of the following: Have you had any rectal pain, mucous in stools, painful bowel 
movements, anal redness, or bleeding after receiving anal sex? 
Answer: No, I am not experiencing any of these symptoms.   
 
Physical Exam Cue Cards:  
 
* After the following systems are assessed during the physical exam, please hand the student the cue card provided. 
Students will verbalize that they will complete the genitourinary and rectal exam.  
 
1. HEENT   
Absence of chancre, oral lesions, and pharyngeal discharge. Pharyngeal erythema and post-nasal drip. 
Erythema and clear secretions in nasal passages. 
2. Skin  
Absence of rashes, lesions, sores, or growths. Skin is warm and dry. 
3. Lymph  
Absence of lymphadenopathy.  
4. Genitourinary Exam  
Absence of penile discharge, lesions, erythema, and warts. Absence of pain/tenderness with palpation of 
penis or scrotum. 
5. Rectal Exam  
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Appendix B  
PrEP and Sexual Healthcare Screening Informational Handout  
Comprehensive Sexual Healthcare Screening and Pre-Exposure Prophylaxis (PrEP) HIV 
Prevention 
 
Fast Facts  
 
Key Points to Ensure a Productive Sexual Health Conversation: 
 
 Ask at least initially, then once every few years: sex assigned at birth, sexual orientation, and 
gender identity.  
o Ask for preferred pronouns to support patient’s current gender identity  
 Establish rapport before asking sensitive questions 
 Use ubiquitous statements to normalize the discussion 
 Pay attention to your own biases and body language  
 Rephrase or explain why you are asking a question if a patient seems offended or reluctant to 
answer 
 
5 P’s of Sexual Healthcare: 
  
 Partners 
o Are you currently sexually active? Have you been sexually active in the past?   
o Do you have sex with men, women, or both? 
o In the past 2 months how many partners have you had sex with? 
o In the past 12 months how many partners have you had sex with? 
 Practices 
o Have you ever had vaginal sex? If so, do you use condoms never, sometimes, or always? 
o Have you had anal sex? If yes, do you use condoms never, sometimes, or always? 
o If you never use condoms, why not?  
o If you sometimes use condoms, in what situations and with whom? 
o Have you had oral sex?  
o Have you ever exchanged sex for commodities? 
o Have you used drugs or alcohol when you had sex?  
 Protection from STIs 
o “What do you do to protect yourself from STIs or HIV?”  
o Have you been vaccinated against HPV, Hepatitis A, or Hepatitis B? 
o Are there other forms of protection from STIs that you would like to discuss today?  
 Past History of STIs  
o Have you ever been tested for HIV, or other STIs? Would you like to be tested?  
o Have you ever been diagnosed with an STI? When? How were you treated?  
o Has your current partner or any former partners ever been diagnosed or treated for an 
STI? Were you tested for the same STI(s)?  
 Prevention of Pregnancy  
o Are you or your partner trying to get pregnant?  
o If no, what are you doing to prevent pregnancy? 
 
Risk Reduction Counseling to Prevent STI/HIV:  
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 Provide basic information about how STIs are transmitted   
 Safe sex practices to reduce transmission and lower risk: 
o Using female/male condoms, lubricants, dental dams with each sexual encounter 
o STI/HIV screening, regular Pap Smears for females   
o Abstinence 
o Reducing the number of sexual partners  
o Recommending contraceptive services  
o No female douching after intercourse 
o Preventative medications: PrEP  
o Use of sterile drug injection equipment or enrollment into drug treatment programs  
o Vaccinations: HPV, Hep A, Hep B  
 HPV vaccination: is recommended through age 26 for women, and through age 
21 for men, if not vaccinated when younger 
 HPV vaccination is also recommended through age 26, if not vaccinated when 
younger: 
 Young men who have sex with men 
 Young adults who are transgender 
 Young adults with weakened immune systems.  
 Provider mediated goal setting  
o If risks are increased by substance use, mental illness, stress, etc., facilitate follow up and 
treatment.   
 
PrEP Quick Facts:  
 
 Once daily oral medication to prevent HIV with almost a 92% efficacy for those who have daily 
adherence  
 Combination of two antiviral drugs used to treat HIV infection: emtricitabine 200mg and 
tenofovir disoproxil fumarate 300mg  
o Drug class: Nucleoside Reverse Transcriptase Inhibitors (NRTI)  
 Prevents HIV from replicating  
 Federally approved for adults ages 18 and older in the United States in 2012 
 Approved by the Food and Drug Administration on May 25, 2018 for youth over 35 kilograms 
o 16 US states allow minor consent for PrEP  
 Kentucky is NOT one of these states  
 Approximately 1.1 million Americans are at risk for HIV transmission as a result of their risk 
factors, but only 18% of these individuals have been prescribed PrEP  
 
High-Risk Sexual Behavior: Indicator for PrEP: 
 
 Individuals with the following behaviors:  
o Sexual partner with HIV  
 Detectable viral load or inconsistent/no antiviral medication  
o Recent bacterial STI  
o Multiple sex partners  
o Inconsistent or no condom use  
o Commercial sex work  
o Use of alcohol or drugs with sexual behavior  
o Men who have sex with men (MSM)  
o Transgender women who participate in receptive anal sex  
 Injection drug users  
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o HIV positive injecting partner  
o Sharing injection equipment  
 
Assessment: ICD-10 Codes:  
 
 Contact with and (suspected) exposure to infections with a predominately sexual mode of 
transportation  
 High risk (bi)(homo)(hetero)sexual behavior  
 
Clinically Eligible:  
 
 HIV negative status BEFORE prescribing PrEP  
o No signs or symptoms of acute HIV infection 
 Rash, fever, chills, headaches, fatigue, sore throat, night sweats, loss of appetite, 
ulcers that appear in the mouth, esophagus, or genitals, swollen lymph nodes, 
muscle aches, diarrhea   
 Renal function within defined limits  
 No contraindicated medications  
o Medications that decrease renal function 
o Other antiviral therapy 
o Allergy to emtricitabine or tenofovir disoproxil fumarate 
 Documented hepatitis B virus infection and vaccination status  
 
PrEP Side Effects:  
  
 “Start-Up Syndrome” most common side effects resolved within the first month of initiating PrEP  
o Most Common: Headache and Nausea/Abdominal Pain  
o Weight Loss  
o Fatigue 
o Diarrhea 
o Back Pain 
o Rash  
o Dizziness  
 Serious Reactions  
o Kidney Failure/ Nephrotoxicity  
o Lactic Acidosis  
o Hepatomegaly/Hepatotoxicity  
o Decreased Bone Mineral Density  
 
Initiation of PrEP: Required Baseline Labs:  
 
 HIV Test  
o HIV Antigen-Antibody Test 4th Generation  
 Acute HIV symptoms or report of unprotected sex in the last month: 
 use both HIV antigen-antibody test and HIV RNA test  
 Renal Function  
o Creatinine Clearance must be ≥ 60mL/min 
o Chronic kidney disease – assess phosphorus  
 Hepatitis B Surface Antigen  
o Patients with chronic hepatitis B can use PrEP, but liver function must be monitored  
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 Pregnancy Test (if applicable) 
 
Initiation of PrEP: Indicated Baseline Labs:  
 
 STI Testing  
o Test from anatomical sites based on subjective patient practice history  
 Urethral, rectal, and pharyngeal sites  
o Syphilis  
 RPR/VDRL 
o Chlamydia  
o Gonorrhea  
 nucleic acid amplification test (NAAT) preferred for both GC and CT  
 Hepatitis C Antibody 
o For MSM, injection drug users, individuals born between 1945-1965 
 
PrEP Counseling:  
  
 PrEP ONLY provides protection from HIV  
o Patients should be educated on continued safe sex practices including condom use  
 Dosing  
o One tablet, once daily, with or without food 
 Adherence  
o Efficacy is strongly correlated with daily dosing  
 Missed Dose  
o Do not double dose. Take next dose when remembered 
 
PrEP Management and Follow-Up:   
 
 Optional 1 Month or Phone Call  
o Confirm HIV negative status  
o Assess for early side effects, adherence barriers, and patient questions 
 Every 3 Months  
o Repeat HIV Testing 
 Assess for signs or symptoms of acute HIV infection 
o Repeat Pregnancy Testing (gender applicable) 
o STI testing for symptomatic patients or asymptomatic MSM (CDC update 2017) 
o Assess medication side effects and interest in continuing PrEP  
o Provide support for medication adherence, including financial support 
o Prescription for NO MORE than 90 day supply (until next HIV test) 
 Every 6 Months (in addition to above):  
o Monitor CrCl 
 Renal decline does not require treatment cessation if CrCl ≥ 60mL/min  
o STI Testing for all individuals even if asymptomatic  
 Chlamydia, Gonorrhea, Syphilis  
 
Patient Tests Positive for HIV while on PrEP:  
 
 Discontinue medication to avoid development of HIV resistance 
o PrEP consists of only one drug class of seven to treat HIV   
 Order HIV genotype  
SIMULATION FOR PREP SEXUAL HEALTH  
 
31 
 Report positive HIV result to health department  
 Refer patient to Infectious Disease/HIV provider for evaluation and treatment 
 
PrEP Resources for Patients:  
 
 CDC has created a data base of PrEP providers 
o https://preplocator.org 
 Payment Assistance through Gilead (Manufacturer of PrEP)  
o Uninsured 
 Advancing Access® Patient Assistance Program 
 https://www.gileadadvancingaccess.com/financial-support/uninsured 
o Commercial Insurance  
 Gilead Co-pay card covers up to $7200 per year with no monthly limit if eligible 
o Government Insurance  
 Independent co-pay foundations 
 
PrEP Resources for Providers:  
 
 CDC Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the United States – 2017 
Update   
o https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf 
 CDC PrEP Physician Hotline  
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Appendix C  
SOAP Note Rubric  
SOAP Note Rubric – High-Risk Sexual Behavior 
 
Participant ID Number: _____________ 
 
Authors: Sara Robertson, DNP, APRN, FNP-C; Mary DeLetter, PhD, RN; Skyler Frye BSN, RN  
 
Scenario: John Brown is a 25-year old Caucasian male who presents to your primary care clinic. He presents today 
with a chief complaint of rhinitis after a recent move to Kentucky. He has not been to a primary care provider in 




___ (5) The 5 P’s of Sexual Health:  
___ (1) Partners: Currently sexually active. 4 male and 2 female partners in the last 2 months. 2 additional 
male partners in the last 12 months.   
___ (1) Practices: Receptive anal sex from 4 male partners, vaginal sex with 2      female partners, and 
performed and received oral sex with all 6 partners. Occasionally drinks alcohol before sex.  
___ (1) Protection from STIs: Wears male condoms “sometimes”. Does not wear condoms because he 
“does not like how they feel”.  
___ (1) Past History of STIs: Chlamydia at 19 years of age that has been treated and resolved. Received a 
test of cure. Agreeable to STI and HIV testing. Past partner was diagnosed with chlamydia.  
___ (1) Prevention of Pregnancy: Practices the “withdrawal” method with female partners and wears 
male condoms occasionally.   
___ (3) Identification of Gender, Gender Identity, Sexual Orientation:  
___ (1) Gender Born:   
  Male  
___ (1) Gender Identity:  
  Male  
___ (1) Sexual Orientation:  
  Bisexual     
__ (1) Past Medical History: 
 Flu 3 months ago with full recovery. (otherwise, unremarkable)   
__ (2) Preventive Health: 
___ (1) HPV Vaccination:   
 Never received Gardasil series.    
___ (1) Hepatitis B Vaccination  
 Up to date.    
__ (1) Current Medications: 
 None.  
__ (1) Allergies: 
 None.  
__(3) Social History: 
 ___ (1) Career/Job  
  Nursing Assistant. Denies commercial sex work.   
 ___ (1) Alcohol use  
Binge drinks 5-6 drinks on weekends. Denies alcohol consumption on weekdays.   
 ___ (1) Drug use 
  Smokes marijuana on rare occasions. Denies IV drug use.    
___(5) Review of Systems: 
 ___ (1) General:  
SIMULATION FOR PREP SEXUAL HEALTH  
 
33 
HIV symptoms: Denies fever, chills, fatigue, night sweats, loss of appetite, recent unintended 
weight loss  
___ (1) HEENT: 
Sore throat and runny nose with clear secretions lasting one week. Denies oral lesions, erythema 
or discharge.  
 ___ (1) Skin:  
  Denies new rashes, growths, lesions, or burning or itching.   
 ___ (1) Genitourinary:  
Occasional dark urine after binge drinking. Denies urinary frequency, urgency, or painful 
urination. No penile discharge, painful ejaculation, or lesions.  
 ___ (1) Rectal:   
Denies rectal pain, mucous in stools, painful bowel movements, anal redness, or bleeding after 
receiving anal sex.  
 
Total Points Subjective Data (21 Points Possible):    
 
Objective Data (focused physical exam): 
 
___ (1) Vitals:  5’11”, 175lbs, BMI=24.4, T=98.6, B/P=128/78, HR=70, RR=14 
___ (1) HEENT: Absence of chancre, oral lesions, and pharyngeal discharge. Pharyngeal erythema and post-nasal 
drip.  
___ (1) Skin: Absence of rashes, lesions, or growths.   
___ (1) Lymph: Absence of lymphadenopathy.   
___ (1) Genitourinary: Absence of penile discharge, lesions, erythema, and warts.  
Absence of pain/tenderness with palpation to penis or scrotum.   
___ (1) Rectal Exam: Absence of lesions, anal discharge, erythema, pain with palpation on DRE  
 




___ (1) High risk bisexual behavior (Z72.53) 
___ (1) Contact with and (suspected) exposure to infections with a predominately  
 sexual mode of transportation (Z20.2)  
 
Total Points Assessment (2 Points Possible):     
Plan:  
 
___ (7) Laboratory Studies:  
 ___ (1) Fourth-generation HIV antigen-antibody test/HIV RNA   
 ___ (1) Hepatitis B screening  
 ___ (1) Serum creatinine/CrCl 
 ___ (1) Chlamydia NAAT/culture  
 ___ (1) Gonorrhea NAAT/culture  
 ___ (1) Syphilis Screening RPR/VDRL 
 ___ (1) Hepatitis C Screening      
___ (2) Medication and Immunizations:  
___ (1) PrEP 90 day supply: emtricitabine 200mg and tenofovir disoproxil fumarate 300mg  
 ___ (1) HPV Vaccination  
___ (3) Behavioral Sexual Risk-Reduction Counseling: 
 ___ (1) Consistent use of condoms.  
 ___ (1) Reduce the number of sexual partners.  
 ___ (1) No drugs or alcohol before sexual behavior.  
___ (5) PrEP Education: 
 ___ (1) Daily adherence.  
 ___ (1) Symptoms of acute HIV infection. 
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___ (1) Discuss serious medication side effects that require evaluation (signs of nephrotoxicity, lactic 
acidosis, hepatotoxicity).  
___ (1) PrEP ONLY protects against HIV. Educate on continued need for safe sex practices.  
___ (1) Required follow-up every 3 and 6 months for scheduled laboratory studies and counseling.  
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Appendix D  
Preamble Consent  
The Use of Simulation to Practice Pre-Exposure Prophylaxis Sexual Health Risk Screening, Management, 
and Follow-up within a Doctor of Nursing Practice Program   
 




You are being invited to participate in a survey about communication principles and caring for a special 
population patient. By answering questions in the attached survey, the project leaders will be able to 
measure the effectiveness of the didactic content combined with simulation on knowledge attainment 
regarding special population care. Additionally, a brief demographic questionnaire and a survey about 
participant satisfaction and self-confidence in learning through the use of simulation will be collected 
after the project intervention has concluded.  
 
Dr. Sara Robertson, Dr. Mary DeLetter, and Skyler Frye of the University of Louisville are conducting 
this survey. There are no known risks for your participation in this survey. There is a theoretical risk of 
mild discomfort addressing topics relating to caring for a special population, but this is not unique to this 
survey given the ubiquitous nature of the existence of special populations of patients seeking care. The 
information collected may not benefit you directly, but may be helpful to others. The information you 
provide may further your educational attainment in this area. Your completed survey will be stored at the 
University of Louisville on Dr. Sara Robertson’s office, 4031 K-wing, in a locked cabinet. The survey 
will take a maximum of 20 minutes to complete. 
 
Individuals from the School of Nursing, the Institutional Review Board (IRB), the Human Subjects 
Protection Program Office (HSPPO), and other regulatory agencies may inspect these records. In all other 
respects, however, the data will be held in confidence to the extent permitted by law. Should the data be 
published, your identity will not be disclosed. 
 
Taking part in this anonymous survey is voluntary. By answering the questions on the following page, 
you agree to take part in this quality improvement project. If you decide to be included in this project, you 
may stop taking part at any time. If you decide not to be in this project or if you stop taking part at any 
time, you will not lose any benefits for which you may qualify. If you choose not to participate in this 
project, pretest question will be released for review the morning of simulation. 
 
If you have any questions, concerns, or complaints about this survey, please contact: Dr. Sara Robertson 
at 502- 852-3801. 
 
If you have any questions about your rights as a participant, you may call the Human Subjects Protection 
Program Office at (502) 852-5188. You can discuss any questions about your rights as a project 
participant, in private, with a member of the Institutional Review Board (IRB). You may also call this 
number if you have other questions about the project, and you cannot reach the project staff, or want to 
talk to someone else. The IRB is an independent committee made up of people from the University 
community, staff of the institutions, as well as people from the community not connected with these 
institutions. The IRB has reviewed this quality improvement project. 
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If you have concerns or complaints about the project or the project staff and you do not wish to give your 
name, you may call 1-877-852-1167. This is a 24-hour hot line answered by people who do not work at 
the University of Louisville. 
 
Sincerely, 
            
Sara Robertson, DNP, APRN, FNP-C   Mary DeLetter, PhD, RN              Skyler Frye, 
BSN, RN 
























Educational Program and Simulation Pretest 
Pre-Test  
 
Participant ID Number: __________ 
 
Participant Demographics  
 
1. Age: ____________ 
 
 2. Select your gender:  
 ___ Male  
 ___ Female  
 ___ Transgender  
 ___ Other (please specify): ___________________ 
 ___ Prefer not to answer  
 
3. Which of the following best describes your racial/ethnic background? 
 ___ African American/Black  
 ___ Caucasian/White  
 ___ Asian or Pacific Islander  
 ___ American Indian or Alaskan Native  
 ___ Hispanic/Latino  
 ___ Mixed or Multiracial  
 ___ Other, please specify: ___________________ 
 ___ Prefer not to answer  
 
4. Has your nurse practitioner clinical experience included providing health care for a member of the LGBTQ 
community? 
___ Yes  
___ No 
 
5. Has your nurse practitioner clinical experience included providing health care for a patient with high-risk sexual 
behavior?  
___ Yes  
___ No  
 
6. Has your nurse practitioner clinical experience included your clinical preceptor or yourself discussing pre-
exposure prophylaxis (PrEP) with a patient? 
___ Yes  
___ No  
 
7.Has your nurse practitioner clinical experience included your clinical preceptor or yourself prescribing PrEP with 
a patient? 
___ Yes  
___ No  
 
8. Have you ever been prescribed PrEP by a provider? 
___ Yes  
___ No  
___ Prefer not to answer  
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9. Identify your level of confidence in your ability to identify candidates for PrEP therapy based on risk factors and 
eligibility in clinical practice:   
___ Very Confident (4)  
 ___ Fairly Confident (3)  
 ___ Lacking in Confidence (2) 
 ___ Extremely lacking in confidence (1) 
 
10. Identify your level of confidence in your ability to elicit a sexual health history with patients in clinical practice:   
___ Very Confident (4)  
 ___ Fairly Confident (3)  
 ___ Lacking in Confidence (2) 
 ___ Extremely lacking in confidence (1) 
 
11. Identify your level of confidence in your ability synthesize a plan for a patient with high-risk sexual practices 
which includes appropriate PrEP follow-up with patients in clinical practice:   
___ Very Confident (4)  
 ___ Fairly Confident (3)  
 ___ Lacking in Confidence (2) 
 ___ Extremely lacking in confidence (1) 
 
Pre-Intervention Pre-Exposure Prophylaxis and Sexual Health Screening Knowledge Assessment: 
 
 By selecting “I agree” below, you agree to not reference any outside materials other than existing knowledge to 
complete the following 9-item test. 
___ I agree  
 
1. A 29 year-year old male presents to the primary care office for his annual exam. Knowing that every adult should 
have a sexual health history completed every year, you begin the discussion.  
 
All of the following are key points to ensure a complete sexual health history EXCEPT:  
 
a.) Establish rapport before asking sensitive questions  
b.) If a patient seems offended or reluctant to answer, continue to medical history  
c.) Ask for preferred pronouns and terminology to support the patient’s current gender identity  
d.) Use ubiquitous statements to normalize the discussion and promote inclusion  
 
2. A 27-year old man presents to your clinic seeking sexually transmitted disease testing. Knowing high-risk sexual 
behavior is an indicator for Pre-Exposure Prophylaxis (PrEP) prescription, in which of the following scenarios is 
PrEP NOT indicated for this individual? 
 
a.) He intermittently uses injection drugs and shares needles  
b.) He is a man who has sex with men (MSM) with an HIV positive partner that irregularly takes his antiviral 
medicine  
c.) He had anal intercourse with a HIV positive man 5 weeks ago and presents with fever, fatigue, and sore throat 
d.) He has unprotected sex with multiple male partners consistently  
 
3. A 22 year-old female patient has had unprotected sex with 6 men in the last three months and presents to your 
primary care office interested in beginning PrEP. She has no symptoms concerning for acute HIV infection. What 
laboratory values studies are required before initiating PrEP?  
 
a.) Hepatitis B surface antigen, serum creatinine, fourth-generation HIV antigen-antibody test, pregnancy test (if 
applicable) 
b.) Hepatitis B surface antigen, alanine aminotransferase (ALT), fourth-generation HIV antigen-antibody test, 
pregnancy test (if applicable) 
c.) Hepatitis B surface antigen, bone mineral density test, fourth-generation HIV antigen-antibody test, pregnancy 
test (if applicable) 
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d) Hepatitis B surface antigen, potassium, fourth-generation HIV antigen-antibody test, pregnancy test (if 
applicable) 
 
4. A 32 year-old bisexual female with no signs or symptoms of an STI takes PrEP as prescribed for six months and 
presents to the primary care office for required repeat laboratory testing. Along with recommended HIV and 
pregnancy testing every 3 months, she should follow-up every 6 months to receive what additional laboratory 
studies?  
  
a.) Renal function testing and bone mineral density scan   
b.) Renal function testing and hepatitis panel   
c.) Renal function testing and tuberculosis screening  
d.) Renal function testing and STI testing  
 
5. What are the most common side effect of PrEP reported by users in the first month? 
 
a.) Rash and pruritis  
b.) Insomnia and anxiety  
c.) Nausea and headache   
d.) Fever and fatigue  
 
6. PrEP provides protection from the following sexually transmitted infections: 
 
a.) Herpes Simplex Virus and HIV  
b.) Chlamydia, Gonorrhea, and HIV  
c.) HIV  
d.) Chlamydia, Gonorrhea, Syphilis, and HIV  
 
7. At PrEP follow-up appointment primary care providers should provide counseling on all of the following 
EXCEPT: 
 
a.) Importance of medication adherence since efficacy of PrEP and daily adherence are strongly correlated  
b.) Safe sex practices such as wearing a condom with each sexual encounter  
c.) Side effects and patient’s interest in continuing medication regimen  
d.) Significance of doubling the dose the next day if one is missed to ensure adequate drug levels  
 
8. A transgender female presents to your primary care office for 6 month follow-up for PrEP therapy. You perform 
laboratory testing and she is positive for Chlamydia and HIV. Knowing your PrEP guidelines you immediately:  
 
a.) Treat her with azithromycin 1 gram PO X 1 day and provide support for PrEP medication-adherence  
b.) Treat her with azithromycin 1 gram PO X 1 day and educate her to discontinue her PrEP prescription to avoid 
development of HIV medication resistance  
c.) Treat her with azithromycin 1 gram PO X 1 day and increase her dose to one tablet BID  
d.) Add an additional antiviral to her medication regimen and refer to infectious disease 
 
9. PrEP is a combination of two medications from what drug class commonly used to treat HIV infections.  
 
a.) Nucleoside Reverse Transcriptase Inhibitors (NRTI) 
b.) Protease Inhibitors (PIs) 
c.) Integrase Inhibitors  
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Appendix F  
Educational Program and Simulation Posttest 
Post-Test  
 
Participant ID Number: __________ 
 
1. Identify your level of confidence in your ability to identify candidates for PrEP therapy based on risk factors and 
eligibility in clinical practice:   
___ Very Confident (4)  
 ___ Fairly Confident (3)  
 ___ Lacking in Confidence (2) 
 ___ Extremely lacking in confidence (1) 
 
2. Identify your level of confidence in your ability to elicit a sexual health history with patients in clinical practice:   
___ Very Confident (4)  
 ___ Fairly Confident (3)  
 ___ Lacking in Confidence (2) 
 ___ Extremely lacking in confidence (1) 
 
3. Identify your level of confidence in your ability synthesize a plan for a patient with high-risk sexual practices 
which includes appropriate PrEP follow-up with patients in clinical practice:   
___ Very Confident (4)  
 ___ Fairly Confident (3)  
 ___ Lacking in Confidence (2) 
 ___ Extremely lacking in confidence (1) 
 
4. Please describe what you liked, did not like, or what could be improved during this experience for high-risk 
sexual behavior.  
 
             
              
              
              
 
Post-Intervention Pre-Exposure Prophylaxis and Sexual Health Screening Knowledge Assessment: 
 
 By selecting “I agree” below, you agree to not reference any outside materials other than existing knowledge to 
complete the following 9-item test. 
___ I agree  
 
1. A 29 year-year old male presents to the primary care office for his annual exam. Knowing that every adult should 
have a sexual health history completed every year, you begin the discussion.  
 
All of the following are key points to ensure a complete sexual health history EXCEPT:  
 
a.) Establish rapport before asking sensitive questions  
b.) If a patient seems offended or reluctant to answer, continue to medical history  
c.) Ask for preferred pronouns and terminology to support the patient’s current gender identity  
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d.) Use ubiquitous statements to normalize the discussion and promote inclusion  
 
2. A 27-year old man presents to your clinic seeking sexually transmitted disease testing. Knowing high-risk sexual 
behavior is an indicator for Pre-Exposure Prophylaxis (PrEP) prescription, in which of the following scenarios is 
PrEP NOT indicated for this individual? 
 
a.) He intermittently uses injection drugs and shares needles  
b.) He is a man who has sex with men (MSM) with an HIV positive partner that irregularly takes his antiviral 
medicine  
c.) He had anal intercourse with a HIV positive man 5 weeks ago and presents with fever, fatigue, and sore throat 
d.) He has unprotected sex with multiple male partners consistently  
 
3. A 22 year-old female patient has had unprotected sex with 6 men in the last three months and presents to your 
primary care office interested in beginning PrEP. She has no symptoms concerning for acute HIV infection. What 
laboratory values studies are required before initiating PrEP?  
 
a.) Hepatitis B surface antigen, serum creatinine, fourth-generation HIV antigen-antibody test, pregnancy test (if 
applicable) 
b.) Hepatitis B surface antigen, alanine aminotransferase (ALT), fourth-generation HIV antigen-antibody test, 
pregnancy test (if applicable) 
c.) Hepatitis B surface antigen, bone mineral density test, fourth-generation HIV antigen-antibody test, pregnancy 
test (if applicable) 
d) Hepatitis B surface antigen, potassium, fourth-generation HIV antigen-antibody test, pregnancy test (if 
applicable) 
 
4. A 32 year-old bisexual female with no signs or symptoms of an STI takes PrEP as prescribed for six months and 
presents to the primary care office for required repeat laboratory testing. Along with recommended HIV and 
pregnancy testing every 3 months, she should follow-up every 6 months to receive what additional laboratory 
studies?  
  
a.) Renal function testing and bone mineral density scan   
b.) Renal function testing and hepatitis panel   
c.) Renal function testing and tuberculosis screening  
d.) Renal function testing and STI testing  
 
5. What is the most common side effect of PrEP reported by users in the first month? 
 
a.) Rash and pruritis  
b.) Insomnia and anxiety  
c.) Nausea and headache   
d.) Fever and fatigue  
 
6. PrEP provides protection from the following sexually transmitted infections: 
 
a.) Herpes Simplex Virus and HIV  
b.) Chlamydia, Gonorrhea, and HIV  
c.) HIV  
d.) Chlamydia, Gonorrhea, Syphilis, and HIV  
 
7. At PrEP follow-up appointment primary care providers should provide counseling on all of the following 
EXCEPT: 
 
a.) Importance of medication adherence since efficacy of PrEP and daily adherence are strongly correlated  
b.) Safe sex practices such as wearing a condom with each sexual encounter  
c.) Side effects and patient’s interest in continuing medication regimen  
d.) Significance of doubling the dose the next day if one is missed to ensure adequate drug levels  




8. A transgender female presents to your primary care office for 6 month follow-up for PrEP therapy. You perform 
laboratory testing and she is positive for Chlamydia and HIV. Knowing your PrEP guidelines you immediately:  
 
a.) Treat her with azithromycin 1 gram PO X 1 day and provide support for PrEP medication-adherence  
b.) Treat her with azithromycin 1 gram PO X 1 day and educate her to discontinue her PrEP prescription to avoid 
development of HIV medication resistance  
c.) Treat her with azithromycin 1 gram PO X 1 day and increase her dose to one tablet BID  
d.) Add an additional antiviral to her medication regimen and refer to infectious disease 
 
9. PrEP is a combination of two medications from what drug class commonly used to treat HIV infections.  
 
a.) Nucleoside Reverse Transcriptase Inhibitors (NRTI) 
b.) Protease Inhibitors (PIs) 
c.) Integrase Inhibitors  
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Appendix G  
NLN Student Satisfaction and Self-Confidence in Learning Survey  
 
